News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015
News Industry News FDA Clears Next-Generation Guide Wire for Cardiovascular Systems' Peripheral Orbital Atherectomy Systems July 07, 2015
News Daily News El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años July 07, 2015
News Daily News Poor Mobility Strongly Predicts Mortality in TAVR Patients Yael L. Maxwell July 06, 2015
News Daily News Un Estudio de un Único Centro Arroja Luz al Debate sobre el Cierre del FOP July 06, 2015
News Industry News Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial July 06, 2015